A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database

• Main Authors: Fan Zou (Author), Chengyu Zhu (Author), Siyu Lou (Author), Zhiwei Cui (Author), Dan Wang (Author), Yingyong Ou (Author), Li Wang (Author), Junyou Chen (Author), Yuanbo Lan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Mepolizumab is primarily used in the treatment of asthma, eosinophilic granulomatosis with polyangiitis, eosinophilia syndrome, and chronic rhinitis with nasal polyps. The information about its adverse drug reactions is mainly derived from clinical trials, and there is a shortage of real-world studi...